Literature DB >> 8001994

NNERVE: neural network extraction of repetitive vectors for electromyography--Part II: Performance analysis.

M H Hassoun1, C Wang, A R Spitzer.   

Abstract

We have presented a new method for the decomposition of clinical electromyographic signals, NNERVE, which utilizes a novel "pseudo-unsupervised" neural network approach to signal decomposition. In this paper, we present a detailed performance analysis. We present definitions for quantitative performance criteria. NNERVE is shown to be highly reliable over a wide range of neural network architectures. It is also minimally sensitive to learning parameters. The degradations of performance over a wide range of signals and parameters are shown to be gradual, slight and graceful. These characteristics are shown to translate directly into a high degree of robustness over widely varying signals. Real signals obtained from the entire range of patients encountered in clinical situations are shown to be correctly handled without any modifications or adjustments of any parameters. This neural network method is then directly compared to a prior traditional signal processing method and is shown quantitatively to have consistently superior performance on both simulated and real signals. Clinically acceptable performance over a wide range of signals, recorded using standard clinical methodology, and the lack of a need for user interaction, will facilitate the use of motor unit quantitation in routine clinical electromyography.

Entities:  

Mesh:

Year:  1994        PMID: 8001994     DOI: 10.1109/10.335843

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

1.  Redesigning the medical office for improved efficiency: an object-oriented event-driven messaging system.

Authors:  S Walczak
Journal:  J Med Syst       Date:  2000-02       Impact factor: 4.460

2.  An artificial neural network approach to diagnosing epilepsy using lateralized bursts of theta EEGs.

Authors:  S Walczak; W J Nowack
Journal:  J Med Syst       Date:  2001-02       Impact factor: 4.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.